Navigation Links
Varian, Inc. Reports Fourth Quarter 2009 Results
Date:11/4/2009

esentation useful to investors' understanding of the company's core operating results and trends, especially when comparing those results on a consistent basis to results for previous periods and anticipated results for future periods. Investors have indicated that they consider financial measures of our results of operations excluding restructuring and other related costs and impairment of private company equity investments as important supplemental information useful to their understanding of our historical results and estimating of our future results.

We also believe that, in excluding acquisition-related intangible and inventory write-up amortization and purchased in-process research and development expenses, costs related to the pending acquisition by Agilent, restructuring and other related costs, and impairment of private company equity investments, our non-GAAP financial measures provide investors with transparency into what is used by management to measure and forecast our results of operations, to compare on a consistent basis our results of operations for the current period to that of prior periods, to compare our results of operations on a more consistent basis against that of other companies, in making financial and operating decisions and to establish certain management compensation.

We believe that the presentation of free cash flow provides investors with useful information on what is used by management to measure cash management performance, in making financial and operating decisions and to establish certain management compensation. Although we believe, for the foregoing reasons, that our presentation of non-GAAP financial measures provides useful supplemental information to investors regarding our results of operations and our cash flows, our non-GAAP financial measures should only be considered in addition to, and not as a substitute for or superior to, our financial measures prepared in accordance with GAAP.

'/>"/>

SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Varian, Inc. to Release Fourth Quarter and Full Fiscal Year 2009 Financial Results
2. Varian, Inc. Delivers a Productivity Increase of Up to 100% With Its 710-ES Series ICP-OES
3. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
4. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
5. Medivation Reports Third Quarter 2009 Financial Results and Provides Corporate Update
6. Cambrex Reports Third Quarter 2009 Results
7. Regeneron Reports Third Quarter 2009 Financial and Operating Results
8. Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
9. Uroplasty Reports Results for Second Quarter FY2010
10. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
11. Mettler-Toledo International Inc. Reports Third Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... HOUSTON , March 3, 2015  Cyberonics, Inc. ... medical devices for the treatment and management of epilepsy, ... Healthcare Conference on Wednesday, March 11, 2015, in ... , Cyberonics, President and Chief Executive Officer, will speak ... conducted in a fireside chat format, and no formal ...
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, Inc., ... cell-derived islet replacement therapy for the treatment of diabetes ... Eugene Brandon , Director of Strategic Relations and ... summit showcases the latest in type 1 diabetes management ... are as follows: , , , Title:   ...
(Date:3/3/2015)... , March 3, 2015  Cannabis Science, Inc. (OTCQB: ... cannabis-based medicine, today announced two important developments: It launched ... global product launches, and CEO Raymond C. Dabney ... HR Examiner. In the article, Dabney answers ... leading a company in an industry that is too ...
Breaking Medicine Technology:ViaCyte to Present at JDRF TypeOneNation Research Summit 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5
... announced that Xeomin ® (incobotulinumtoxinA), a new botulinum toxin ... (CD)or blepharospasm, is now commercially available in the U.S. XEOMIN ... on July 30, 2010. XEOMIN is a botulinum ... is FDA-approved for the treatment of adults with cervical dystonia, ...
... 5 Lixte Biotechnology Holdings (OTC: ... Experimental Therapeutics (NExT) Program Senior Advisory Committee (SAC), ... Cancer Institute (NCI), National Institutes of Health (NIH), ... collaboration with Lixte Biotechnology Holdings, Inc. for clinical ...
Cached Medicine Technology:Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 2Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 3Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 4Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 5Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S. 6Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100. 2Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100. 3
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... is estimated to grow from $1,224.6 million ... 6.71% between 2014 and 2019. , Browse ... delivery network market for an analysis of ... of various tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html ...
(Date:3/3/2015)... Ann Arbor, MI (PRWEB) March 03, 2015 ... on NPR News Morning Edition, science correspondent Shankar Vedantam ... the University of Pennsylvania about the drastic decrease in hand-hygiene ... shift. He suggested that the problem could be solved in ... to perform hand hygiene when they enter and exit a ...
(Date:3/3/2015)... 03, 2015 Birth Boot Camp ... they now have over 130 certified instructors in more ... Germany. In addition, the company recently launched a new ... childbirth educator certification program . Birth Boot Camp is ... birth partner. The practical information can be used by ...
(Date:3/3/2015)... Vancouver, BC (PRWEB) March 03, 2015 ... iData Research ( http://www.idataresearch.com ), market saturation has ... of care in the United States. Unit sales ... continue to increase as facilities replace older systems, ... neurosurgery navigation system market is very much a ...
(Date:3/3/2015)... Celestix Networks, the leading provider of ... global availability of Celestix Cloud Edge Security Appliance ... deployed platform for DirectAccess and remote access roles ... release enables organizations to manage the Windows® Server ... HTML 5 web interface called Comet 2.0. ...
Breaking Medicine News(10 mins):Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3Health News:Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 2Health News:Neurosurgery Navigation System Market Reaches Saturation in the United States 3Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3
... our stomach may reduce the protective effects of antioxidants ... Glasgow found that in the presence of lipid the ... component of vitamin C), to protect against the generation ... than when no lipids are present. “Our results illustrate ...
... the blues? There’s nothing like getting down and dirty say ... ,The study led by Dr. Chris Lowry ... Mycobacterium vaccae, can actually replicate the effects of anti- depressant ... of lung cancer patients who were treated with the ...
... at those simple, inexpensive, often boisterous bistros that made Paris ... ,The reason is that a number of young chefs, ... to exercise their talents in the casual atmosphere of a ... of vying for a Michelin star. ,As a ...
... California, San Diego (UCSD) School of Medicine have discovered ... with increased clotting of the blood, which has previously ... published in the March issue of CHEST, the official ... ,'In previous work, we have found that sleep ...
... be hailed as a leprosy-free zone by health administrators worldwide. ... more are suffering// from the terrifying disease. ,But ... point out. And the stigma the disease carries with it ... an ancient, much feared disease. But although it is infectious ...
... showing actors blowing glorious rings of smoke or village ... reach for those below 18 years//. ,An ... against tobacco consumption has suggested that films showing smoking ... ,Public Health Foundation of India (PHFI), an autonomous ...
Cached Medicine News:Health News:Be Happy- Get On Your Knees And Play In The Mud 2Health News:'Bistronomy' is Conquering Dining in Paris 2Health News:'Bistronomy' is Conquering Dining in Paris 3Health News:Indian Films With Smoking Scenes may Get 'A' Certificate 2
SURGISPIKE™ Single Use 5 mm Trocar. , ,Bladed Trocars are devices that contain a metal blade to gain access to the abdominal cavity....
... The complete line of Surgical Access ... ,The OnePort™ trocar system is actually ... be versatile, operationally flexible and clinically adaptive ... offering options in disposability and bladed or ...
... of Surgical Access ...unlike any trocar system ... system is actually four systems in one ... and clinically adaptive to all of your ... and bladed or dilating tip styles, OnePort™ ...
... FPK01 Thoracic Trocar Pak ... 15mm flexible sleeves and (1) ... ,FPK02 Thoracic Trocar Pak ... 15mm flexible sleeves., ,FPK03 ...
Medicine Products: